Medera Inc. ("Medera"), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing ...
Preclinical data with a gene therapy has shown potential to restore cardiac function in a rat model of for heart failure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback